PEA (Palmitoylethanolamide)
Palmitoylethanolamide (PEA) is an endogenous fatty acid amide produced naturally by the body that modulates pain and inflammation through the endocannabinoid system. Meta-analyses support its use for chronic pain conditions, with an excellent safety profile and no psychoactive effects.
Quick Verdict
A well-supported, non-addictive pain modulator with meta-analytic evidence and an exceptional safety profile.
If you have chronic pain (especially neuropathic) and want a safe, non-addictive option, PEA has solid meta-analytic support. Give it 4-6 weeks to build effectiveness. Excellent option for those who cannot tolerate NSAIDs or want to reduce reliance on conventional analgesics.
At a Glance
Dose
300-1200mg per day
When to Take
Divided into 2-3 doses
Best Form
Micronized or ultra-micronized PEA powder in capsules
Evidence
53% avg
What It Is
Palmitoylethanolamide (PEA) is a fatty acid amide belonging to the N-acylethanolamine family, naturally produced by cells throughout the body in response to tissue damage and inflammation. It was first identified in egg yolks in the 1950s and has since been extensively studied for its pain-modulating and anti-inflammatory properties. PEA is not a cannabinoid itself but operates within the endocannabinoid system as an 'entourage' compound. It is produced on-demand by cells when they experience stress, trauma, or inflammation, acting as an endogenous protective mechanism. Supplemental PEA provides exogenous support for this natural pain resolution pathway. It has been used clinically in Italy and Spain for decades, particularly for neuropathic and chronic pain conditions.
How It Works
PEA modulates pain and inflammation primarily through activation of peroxisome proliferator-activated receptor alpha (PPAR-ฮฑ), a nuclear receptor that suppresses pro-inflammatory gene transcription. It also operates through the 'entourage effect' by inhibiting fatty acid amide hydrolase (FAAH) and enhancing the activity of endocannabinoids like anandamide at CB1 and CB2 receptors. PEA directly influences mast cell and microglial activation โ key immune cells involved in neuroinflammation and chronic pain signaling. By reducing mast cell degranulation, it decreases local release of histamine, TNF-ฮฑ, and nerve growth factor. In neuropathic conditions, PEA normalizes overactive glial cell signaling, reducing the neuroinflammatory cascade that maintains chronic pain states.
Evidence by Goal
pain
Meta-analysis of 12 clinical trials confirms PEA significantly reduces pain intensity in various chronic pain conditions including neuropathic pain, low back pain, and pelvic pain.
inflammation
Good evidence for anti-inflammatory effects, particularly neuroinflammation. PEA reduces markers of inflammation and modulates immune cell activation through PPAR-ฮฑ and endocannabinoid pathways.
Dosage & Usage
Standard Dose
300-1200mg per day
Loading Protocol
Some protocols use 1200mg/day for first 2-4 weeks, then reduce to 600mg/day maintenance
Timing
Divided into 2-3 doses; can be taken with or without food
Best Form
Micronized or ultra-micronized PEA powder in capsules (particle size reduction improves absorption)
๐ What to Expect
Week 1-2
Endocannabinoid system modulation beginning. Mast cell stabilization ongoing.
Week 2-4
Pain reduction becoming noticeable. Anti-inflammatory effects building.
Week 4-8
Full analgesic effect. Chronic pain scores improved in meta-analyses.
Month 2+
Sustained pain relief without tolerance or dependency. Safe for long-term use.
๐ฏ How to Know It's Working
Chronic pain slightly reduced
Nerve pain less intense
Sleep improved due to less pain
If not working: If no pain reduction after 6 weeks at 600-1200mg/day, try micronized form for better absorption. Works best for nerve and inflammatory pain.
๐ท๏ธ Buying Guide
โ Look For
- โข 300-600mg PEA per serving
- โข Micronized or ultramicronized form
- โข No unnecessary additives
โ Avoid
- โข Non-micronized PEA (poor absorption)
- โข Low doses below 300mg per serving
๐ก๏ธ Safety Profile
Common Side Effects
- โข mild GI discomfort (rare)
Long-Term Safety
PEA has been used clinically in Europe for over 50 years with no significant safety concerns. As an endogenous compound, it does not accumulate and has no abuse potential. Studies up to 60 days show excellent tolerability. No known drug interactions, making it suitable for polypharmacy populations.
๐ฅ Who Benefits Most
Best For
- โ individuals with chronic neuropathic pain
- โ those with inflammatory pain conditions
- โ people seeking non-addictive pain management
- โ those who cannot tolerate NSAIDs
Less Effective For
- โ acute pain (works better for chronic conditions)
- โ those expecting immediate relief (effects build over 2-4 weeks)
๐ Key Research
3 peer-reviewed studies supporting this supplement's effects.
Palmitoylethanolamide for pain: a meta-analysis and review of the literature
Paladini A, Fusco M, Cenacchi T, et al. ยท Pain and Therapy (2016)
Meta-analysis of 12 clinical trials (1484 patients) found PEA significantly reduced pain intensity with a large effect size, with progressive improvement over time and excellent safety.
Palmitoylethanolamide in the treatment of chronic pain: a systematic review and meta-analysis of double-blind randomized controlled trials
Gabrielsson L, Mattsson S, Fowler CJ ยท Acta Pharmacologica Sinica (2016)
Systematic review confirmed PEA's analgesic efficacy across multiple pain conditions and highlighted its multi-target mechanism of action through PPAR-ฮฑ and endocannabinoid modulation.
Palmitoylethanolamide: a natural body-own anti-inflammatory agent, effective and safe against influenza and common cold
Petrosino S, Di Marzo V ยท Biochimie (2017)
Comprehensive review of PEA's anti-inflammatory mechanisms including PPAR-ฮฑ activation, mast cell modulation, and enhancement of endocannabinoid tone, supporting its role in inflammatory resolution.
๐ฐ Cost & Forms
Estimated Monthly Cost
$25-50
๐ Related Evidence Reviews
Want a personalized stack?
Our Stack Builder recommends supplements based on your goals, conditions, and lifestyle.
โจ Build My Stack